Abbott Laboratories DRC (ABT)

Currency in CAD
16.21
-0.07(-0.43%)
Real-time Data·
ABT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.2116.22
52 wk Range
16.0524.81
Key Statistics
Bid/Ask
16.20 / 16.22
Prev. Close
16.28
Open
16.22
Day's Range
16.21-16.22
52 wk Range
16.05-24.81
Volume
543
Average Volume (3m)
6.84K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Employees
115000
Market
Canada

Compare ABT to Peers and Sector

Metrics to compare
ABT
Peers
Sector
Relationship
P/E Ratio
25.5x25.4x−0.4x
PEG Ratio
−0.47−2.300.00
Price/Book
3.1x2.7x2.6x
Price / LTM Sales
3.5x2.3x3.2x
Upside (Analyst Target)
-11.2%46.7%
Fair Value Upside
Unlock1.7%7.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.57%
Dividend Yield
2.71%
Industry Median 1.03%
Annualized payout
0.44
Paid quarterly
5-Years Growth
+8.54%
Growth Streak

Earnings

Latest Release
Apr 16, 2026
EPS / Forecast
0.61 / --
Revenue / Forecast
11.16B / --
EPS Revisions
Last 90 days

ABT Income Statement

People Also Watch

FAQ

What Is the Abbott Laboratories DRC (ABT) Stock Price Today?

The Abbott Laboratories DRC stock price today is 16.21 CAD.

What Stock Exchange Does Abbott Laboratories DRC Trade On?

Abbott Laboratories DRC is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Abbott Laboratories DRC?

The stock symbol for Abbott Laboratories DRC is "ABT."

Does Abbott Laboratories DRC Pay Dividends? What’s The Current Dividend Yield?

The Abbott Laboratories DRC dividend yield is 2.71%.

What Is the Abbott Laboratories DRC Market Cap?

As of today, Abbott Laboratories DRC market cap is 220.70B CAD.

What Is Abbott Laboratories DRC's Earnings Per Share (TTM)?

The Abbott Laboratories DRC EPS (TTM) is 3.57.

From a Technical Analysis Perspective, Is ABT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Abbott Laboratories DRC Stock Split?

Abbott Laboratories DRC has split 0 times.

How Many Employees Does Abbott Laboratories DRC Have?

Abbott Laboratories DRC has 115000 employees.

What is the current trading status of Abbott Laboratories DRC (ABT)?

As of Apr 24, 2026, Abbott Laboratories DRC (ABT) is trading at a price of 16.21 CAD, with a previous close of 16.28 CAD. The stock has fluctuated within a day range of 16.21 CAD to 16.22 CAD, while its 52-week range spans from 16.05 CAD to 24.81 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.